Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis | The BMJ

https://www.bmj.com/content/378/bmj-2021-067606

Joseph Thornton

Published by Joseph Thornton MD

Teacher, Clinical Supervisor Clinical Associate Professor, Psychiatry University of Florida Affiliation is for identification only. All content and opinions are my own.

Leave a comment